IL98090A - Dihydrobenzofiran-2-carboxylic acids converted by alkoxy and their history and pharmaceutical preparations containing them - Google Patents

Dihydrobenzofiran-2-carboxylic acids converted by alkoxy and their history and pharmaceutical preparations containing them

Info

Publication number
IL98090A
IL98090A IL9809091A IL9809091A IL98090A IL 98090 A IL98090 A IL 98090A IL 9809091 A IL9809091 A IL 9809091A IL 9809091 A IL9809091 A IL 9809091A IL 98090 A IL98090 A IL 98090A
Authority
IL
Israel
Prior art keywords
propyl
carbon atoms
compound
dihydro
benzopyran
Prior art date
Application number
IL9809091A
Other languages
English (en)
Hebrew (he)
Other versions
IL98090A0 (en
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of IL98090A0 publication Critical patent/IL98090A0/xx
Publication of IL98090A publication Critical patent/IL98090A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL9809091A 1990-05-10 1991-05-09 Dihydrobenzofiran-2-carboxylic acids converted by alkoxy and their history and pharmaceutical preparations containing them IL98090A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/521,777 US5073562A (en) 1990-05-10 1990-05-10 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof

Publications (2)

Publication Number Publication Date
IL98090A0 IL98090A0 (en) 1992-06-21
IL98090A true IL98090A (en) 1995-07-31

Family

ID=24078110

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9809091A IL98090A (en) 1990-05-10 1991-05-09 Dihydrobenzofiran-2-carboxylic acids converted by alkoxy and their history and pharmaceutical preparations containing them

Country Status (16)

Country Link
US (1) US5073562A (fr)
EP (1) EP0527922B1 (fr)
JP (1) JPH05507084A (fr)
AT (1) ATE119528T1 (fr)
AU (1) AU647487B2 (fr)
CA (1) CA2082500A1 (fr)
DE (1) DE69108025T2 (fr)
DK (1) DK0527922T3 (fr)
ES (1) ES2069295T3 (fr)
GR (1) GR3015349T3 (fr)
IE (1) IE62719B1 (fr)
IL (1) IL98090A (fr)
NZ (1) NZ238092A (fr)
PT (1) PT97614A (fr)
WO (1) WO1991017160A1 (fr)
ZA (1) ZA913546B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677021B1 (fr) * 1991-05-31 1993-10-01 Upsa Laboratoires Nouveaux derives de thiazole antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
US5352690A (en) * 1992-07-01 1994-10-04 Eli Lilly And Company 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists
AU2585595A (en) * 1994-05-25 1995-12-18 G.D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-sulfonimides derivatives, their preparation and their use as leukotriene b4 antagonists
US5516917A (en) * 1994-06-08 1996-05-14 G. D. Searle & Co. Leukotriene B4 antagonists
AU696890B2 (en) * 1994-10-13 1998-09-24 Pfizer Inc. Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists
CA2202056A1 (fr) * 1994-10-13 1996-04-25 Mark A. Dombroski Composes de benzopyranne et composes benzo-fusionnes, leur preparation et leur utilisation comme antagonistes du leucotriene b4' (ltb4)
AU1707700A (en) * 1998-10-29 2000-05-22 Bristol-Myers Squibb Company Novel inhibitors of impdh enzyme
PE20020453A1 (es) 2000-09-27 2002-06-06 Merck & Co Inc Derivados del acido benzopirancarboxilico para el tratamiento de la diabetes y los trastornos de lipidos
EP1347755A2 (fr) * 2000-10-31 2003-10-01 Merck & Co., Inc. Derives d'acide benzopyranocarboxylique pour traiter le diabete et d'autres troubles lipidiques
US7446127B2 (en) * 2003-08-27 2008-11-04 Sk Holdings Co, Ltd. Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders
EP3492602A1 (fr) 2005-06-15 2019-06-05 Complete Genomics, Inc. Réseaux de molécules simples pour l'analyse génétique et chimique
EP1951900B1 (fr) 2005-10-07 2016-06-15 Callida Genomics, Inc. Biopuces à molécules simples autoassemblées et utilisations
CA2643700A1 (fr) 2006-02-24 2007-11-22 Callida Genomics, Inc. Sequencage genomique a haut debit sur des puces a adn
EP2766498B1 (fr) 2011-10-14 2019-06-19 President and Fellows of Harvard College Séquençage par assemblage structurel
WO2013184754A2 (fr) 2012-06-05 2013-12-12 President And Fellows Of Harvard College Séquençage spatial d'acides nucléiques à l'aide de sondes d'origami d'adn
US9476089B2 (en) 2012-10-18 2016-10-25 President And Fellows Of Harvard College Methods of making oligonucleotide probes
US9540685B2 (en) 2013-03-15 2017-01-10 President And Fellows Of Harvard College Methods of identifying homologous genes using FISH
CN107075546B (zh) 2014-08-19 2021-08-31 哈佛学院董事及会员团体 用于对核酸探测并作图的rna-引导的系统
US20230109070A1 (en) 2019-10-18 2023-04-06 The Board of Trustees og the Leland Standford Junior University Clinical- and industrial-scale intact-tissue sequencing
US20220228200A1 (en) 2021-01-19 2022-07-21 10X Genomics, Inc. Methods and compositions for internally controlled in situ assays
CN117396613A (zh) 2021-06-01 2024-01-12 10X基因组学有限公司 用于分析物检测和探针解析的方法和组合物
EP4347880A1 (fr) 2021-06-02 2024-04-10 10X Genomics, Inc. Analyse d'échantillon à l'aide de sondes circularisables asymétriques
CN117651855A (zh) 2021-07-13 2024-03-05 10X基因组学有限公司 用于制备具有可控厚度的聚合基质的方法
WO2023015192A1 (fr) 2021-08-03 2023-02-09 10X Genomics, Inc. Concatémères d'acide nucléique et procédés de stabilisation et/ou de compactage de ceux-ci
US20230061542A1 (en) 2021-08-16 2023-03-02 10X Genomics, Inc. Probes comprising a split barcode region and methods of use
US20230242974A1 (en) 2021-12-27 2023-08-03 10X Genomics, Inc. Methods and compositions for rolling circle amplification
US20230279475A1 (en) 2022-01-21 2023-09-07 10X Genomics, Inc. Multiple readout signals for analyzing a sample
WO2023164570A1 (fr) 2022-02-23 2023-08-31 Insitro, Inc. Criblage optique groupé et mesures transcriptionnelles de cellules comprenant des perturbations génétiques à code-barres
WO2023215603A1 (fr) 2022-05-06 2023-11-09 10X Genomics, Inc. Procédés et compositions pour l'analyse in situ de séquences v(d)j
WO2023245190A1 (fr) 2022-06-17 2023-12-21 10X Genomics, Inc. DÉ-RÉTICULATION CATALYTIQUE D'ÉCHANTILLONS POUR ANALYSE IN SITU <i />
US20240191297A1 (en) 2022-10-14 2024-06-13 10X Genomics, Inc. Methods, compositions, and systems for assessing biological sample quality
WO2024102736A1 (fr) 2022-11-08 2024-05-16 10X Genomics, Inc. Procédés et compositions d'immobilisation pour détection in situ
US20240158852A1 (en) 2022-11-16 2024-05-16 10X Genomics, Inc. Methods and compositions for assessing performance of in situ assays
WO2024130203A1 (fr) 2022-12-16 2024-06-20 10X Genomics, Inc. Procédés et compositions d'évaluation de performances

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384530A (en) * 1971-07-29 1975-02-19 Fisons Ltd Chromone derivatives
EP0017332B1 (fr) * 1979-03-20 1985-07-31 FISONS plc Composés hétérocycliques à activité pharmaceutique, procédés pour leur préparation et compositions les contenant
US4474788A (en) * 1981-11-12 1984-10-02 Fisons Plc Anti-SRSA quinoline carboxylic acid derivatives
US4788214A (en) * 1983-06-24 1988-11-29 Hoffman-La Roche Inc. 3,4-dihydro-2H-1-benzopyran derivatives
ZA844519B (en) * 1983-06-24 1985-02-27 Hoffmann La Roche Dihydrobenzopyran derivatives
US4665203A (en) * 1983-08-08 1987-05-12 G. D. Searle & Co. Substituted dihydrobenzopyrans useful as leukotriene D4 inhibitors
US4778903A (en) * 1983-12-12 1988-10-18 G. D. Searle & Co. Substituted dihydrobenzopyrans
ZA84345B (en) * 1983-08-08 1985-02-27 Searle & Co Substituted dihydrobenzopyrans
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
US4546194A (en) * 1984-05-29 1985-10-08 G. D. Searle & Co. Substituted chromanon-2-yl alkanols and derivatives thereof
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
MX13485A (es) * 1987-10-19 1993-05-01 Pfizer Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos

Also Published As

Publication number Publication date
AU647487B2 (en) 1994-03-24
IL98090A0 (en) 1992-06-21
DK0527922T3 (da) 1995-05-22
EP0527922B1 (fr) 1995-03-08
CA2082500A1 (fr) 1991-11-11
DE69108025D1 (de) 1995-04-13
ES2069295T3 (es) 1995-05-01
IE62719B1 (en) 1995-02-22
WO1991017160A1 (fr) 1991-11-14
ATE119528T1 (de) 1995-03-15
US5073562A (en) 1991-12-17
NZ238092A (en) 1993-10-26
AU7902091A (en) 1991-11-27
IE911583A1 (en) 1991-11-20
EP0527922A1 (fr) 1993-02-24
ZA913546B (en) 1992-07-29
DE69108025T2 (de) 1995-08-10
GR3015349T3 (en) 1995-06-30
PT97614A (pt) 1992-01-31
JPH05507084A (ja) 1993-10-14

Similar Documents

Publication Publication Date Title
AU647487B2 (en) Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
EP0593478B1 (fr) Antagonistes de leukotriene b 4
EP0605729B1 (fr) Derive d&#39;oxazolidine et son sel pharmaceutiquement acceptable
JP4276074B2 (ja) ペルオキシソーム増殖剤応答性受容体δの活性化剤
EP0243018B1 (fr) Dérivés d&#39;acide thiolactame-N-acétique, leur préparation et leur application
EP0456835A1 (fr) Derive de l&#39;acide quinazoline-3-alcanoique, sels derives de ce compose et sa production
KR20000016412A (ko) 신규한 치환 2,4-티아졸리디네디온 유도체, 이의제조 방법 및이를 함유하는 약제학적 조성물
US4746669A (en) Substituted thiazoles as immunoregulants
EP0528935B1 (fr) Acides dihydrobenzopyran-2-carboxyliques a substitution alcoxy et leurs derives
US5516917A (en) Leukotriene B4 antagonists
US5192782A (en) Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
US5212198A (en) Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
US5578619A (en) Alkoxy-substituted dihydrobenzopyran-2-sulfonimides
US5380740A (en) Anti-inflammatory compounds, compositions and method of use thereof
JPH04270273A (ja) チアゾリジン−2,4−ジオン誘導体とその塩及びその製造法
US4855426A (en) Process of preparing 1,5-epoxy-2,3,4,5-tetrahydro-1H-3-benzazepins
US4761413A (en) 1,5-epoxy-2,3,4,5-tetrahydro-1H-3-benzazepins and use in treatment of ulcers
IE914409A1 (en) Anti-inflammatory compounds
US4910198A (en) 1,5-epoxy-2,3,4,5-tetrahydro-1H-3-benzazepins

Legal Events

Date Code Title Description
RH Patent void